BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8252943)

  • 21. Activation of coagulation system in dilated cardiomyopathy: comparison of patients with and without left ventricular thrombus.
    Riza Erbay A; Turhan H; Aksoy Y; Senen K; Yetkin E
    Coron Artery Dis; 2004 Aug; 15(5):265-8. PubMed ID: 15238823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise-induced myocardial ischemia in patients with coronary artery disease: lack of evidence for platelet activation or fibrin formation in peripheral venous blood.
    Marcella JJ; Nichols AB; Johnson LL; Owen J; Reison DS; Kaplan KL; Cannon PJ
    J Am Coll Cardiol; 1983 May; 1(5):1185-93. PubMed ID: 6339591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation disorders and tumor markers in the diagnosis of pancreatic cancer.
    Abbasciano V; Graziano L; Guerra S; Mazzotta D; Pollinzi V; Gilli G; Zavagli G
    Oncology; 1991; 48(5):377-82. PubMed ID: 1720884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
    Ogawa H; Yasue H; Oshima S; Okumura K; Matsuyama K; Obata K
    Circulation; 1989 Dec; 80(6):1617-26. PubMed ID: 2532074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic effects of collagen-impregnated aortoiliac Dacron vascular prostheses on platelet activation and fibrin formation.
    De Mol Van Otterloo JC; Van Bockel JH; Ponfoort ED; Briet E; Brommer EJ; Hermans J; Daha MR
    J Vasc Surg; 1991 Jul; 14(1):59-66. PubMed ID: 1829489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet and fibrin metabolism in recipients of the Jarvik 7 total artificial heart.
    Ring ME; Feinberg WM; Levinson MM; Bruck DC; Smith RG; Icenogle TM; Copeland JG
    J Heart Transplant; 1989; 8(3):225-32. PubMed ID: 2525612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
    Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
    Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrin formation and platelet activation in patients with myocardial infarction and normal coronary arteries.
    Rapold HJ; Haeberli A; Kuemmerli H; Weiss M; Baur HR; Straub WP
    Eur Heart J; 1989 Apr; 10(4):323-33. PubMed ID: 2524385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves.
    Dudczak R; Niessner H; Thaler E; Lechner K; Kletter K; Frischauf H; Domanig E; Aicher H
    Haemostasis; 1981; 10(4):186-94. PubMed ID: 6454613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis.
    Kowal-Bielecka O; Kowal K; Lewszuk A; Bodzenta-Lukaszyk A; Walecki J; Sierakowski S
    Ann Rheum Dis; 2005 Mar; 64(3):484-6. PubMed ID: 15708900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular markers of hemostasis activation in nephrotic syndrome.
    Sagripanti A; Cupisti A; Ferdeghini M; Pinori E; Barsotti G
    Nephron; 1989; 51(1):25-8. PubMed ID: 2521695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers of thrombotic activity in arterial disease.
    Donaldson MC; Matthews ET; Hadjimichael J; Rickles FR
    Arch Surg; 1987 Aug; 122(8):897-900. PubMed ID: 2957982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia.
    Borok Z; Weitz J; Owen J; Auerbach M; Nossel HL
    Blood; 1984 Mar; 63(3):525-31. PubMed ID: 6230118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia.
    Gallino A; Haeberli A; Baur HR; Straub PW
    Circulation; 1985 Jul; 72(1):27-30. PubMed ID: 2408785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
    Douglas JT; Lowe GD; Forbes CD; Prentice CR
    Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in hemostasis activity during delivery and the immediate postpartum period.
    Gerbasi FR; Bottoms S; Farag A; Mammen EF
    Am J Obstet Gynecol; 1990 May; 162(5):1158-63. PubMed ID: 2140236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage.
    Librenti MC; D'Angelo A; Micossi P; Garimberti B; Mannucci PM; Pozza G
    Acta Diabetol Lat; 1985; 22(1):39-45. PubMed ID: 2408434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.